Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed.The ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...

ProMIS Neurosciences (PMN) announced the initiation of its Phase 1b clinical trial evaluating its lead therapeutic candidate, PMN310, in ...